UNIVERSITE PARIS CITE
85 Bd Saint Germain – Paris – 75006
VAT: FR65130025737
nan
Complicit EU Projects
Within the Horizon 2020 (2014-2020) framework, UNIVERSITE PARIS CITE has received € 1,679,684.0 for its participation in a total of 10 project(s) with a total cost of € 104,054,793.
| Start (YYYYMMDD) | Project ID | Project Name | Themes | End (YYYYMMDD) | Role | EC Contribution | Total Cost | IL Participation | Total Participation | CORDIS Link |
|---|---|---|---|---|---|---|---|---|---|---|
| 2016-01-01 | 668023 | PIBD-SETQuality | inflammatory bowel disease · productivity · oncology · paediatrics · employment | 2021-06-30 | coordinator | € 580,000.0 | € 5,996,000 | 2 | 14 | CORDIS ↪ |
| 2021-07-01 | 951541 | Quantropy | graphene · quantum physics · fermions · thermodynamics · mesoscopic physics | 2027-06-30 | thirdParty | € 0.0 | € 13,476,506 | 2 | 7 | CORDIS ↪ |
| 2016-04-01 | 693349 | SIGN-HUB | sign language · history · civil society · cognitive psychology · psycholinguistics | 2020-04-30 | participant | € 220,287.5 | € 2,518,737 | 1 | 10 | CORDIS ↪ |
| 2016-10-01 | 713694 | MULTIPLY | 2022-09-30 | partner | € nan | € 6,372,000 | 1 | 45 | CORDIS ↪ | |
| 2021-01-28 | 101037867 | VACCELERATE | pandemics · coronaviruses · vaccines | 2024-01-27 | participant | € 262,500.0 | € 26,499,804 | 1 | 32 | CORDIS ↪ |
| 2015-04-01 | 633168 | BIOCYCLE | inflammatory diseases · immunotherapy | 2022-12-31 | thirdParty | € 0.0 | € 5,962,096 | 1 | 17 | CORDIS ↪ |
| 2019-03-01 | 821558 | IMMUcan | databases · oncology · immunotherapy · microbiology | 2025-08-31 | participant | € 79,220.0 | € 35,779,304 | 1 | 31 | CORDIS ↪ |
| 2019-01-01 | 813533 | MLFPM2018 | data science · genetics · personalized medicine · statistics and probability · machine learning | 2024-03-31 | participant | € 0.0 | € 3,618,387 | 1 | 17 | CORDIS ↪ |
| 2019-01-01 | 813533 | MLFPM2018 | data science · genetics · personalized medicine · statistics and probability · machine learning | 2024-03-31 | participant | € 274,802.04 | € 3,618,387 | 1 | 17 | CORDIS ↪ |
| 2017-09-01 | 766214 | META-CAN | drug discovery · entrepreneurship · cell metabolism · immunology · oncology | 2021-08-31 | participant | € 262,875.6 | € 3,831,957 | 3 | 20 | CORDIS ↪ |
Within the Horizon Europe (2021-2027) framework, UNIVERSITE PARIS CITE has received € 1,939,875.0 for its participation in a total of 3 project(s) with a total cost of € 19,393,621.
| Start (YYYYMMDD) | Project ID | Project Name | Themes | End (YYYYMMDD) | Role | EC Contribution | Total Cost | IL Participation | Total Participation | CORDIS Link |
|---|---|---|---|---|---|---|---|---|---|---|
| 2022-08-01 | 101058509 | ECS | 2026-07-31 | participant | € 439,875.0 | € 3,999,043 | 1 | 21 | CORDIS ↪ | |
| 2023-01-01 | 101093110 | EXTRACT | smart cities · 5G · internet of things · data mining · sensors | 2025-12-31 | thirdParty | € 0.0 | € 4,997,875 | 1 | 12 | CORDIS ↪ |
| 2023-12-01 | 101136622 | THRIVE | artificial intelligence · liver cancer · mortality · surgical procedures · microbiology | 2028-11-30 | participant | € 1,500,000.0 | € 10,396,703 | 1 | 13 | CORDIS ↪ |
UNIVERSITE PARIS CITE did not participate in FP7 (2007-2013).